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The KEAP1 (Kelch-like ECH-associated protein 1)-NRF2 (NF-E2-related factor 2) 2 
system controls the biochemical defense activity against agents toxic to mammals and 3 
responds to exogenous and endogenous stressors such as electrophilic and oxidative 4 
substances, which can have destructive and genotoxic effects on affected mammalian 5 
tissues. Although this system can be activated by various environmental stressors, it 6 
remains unclear whether ultraviolet radiation (UVR), which is one of the major 7 
environmental agents that has inflammatory and carcinogenic impacts on human skin and 8 
eyes, induces NRF2-dependent defense activity. Here, we review the recent progress in 9 
the study of the contributions of NRF2 and related factors to protection against UVR. The 10 
KEAP1-NRF2 system is not always efficient in responding to UVR, especially to short 11 
wavelengths such as UVC/UVB, indicating that UVR is a poor activator of the KEAP1-12 
NRF2 system. However, sustained activation of NRF2 appears to suppress the harmful 13 
effects of chronic UVR exposure, such as photoaging of and carcinogenesis in the skin, 14 
indicating that NRF2 activation is beneficial for the protection of the skin from the 15 
harmful effects of UVR. However, it should be noted that prolonged and strong activation 16 
of NRF2 may also have adverse effects on skin, especially in the case of UVR-induced 17 
carcinogenesis. We present working models describing mechanisms underlying the 18 
involvement of the KEAP1-NRF2 system in skin photoaging and carcinogenesis. 19 
 20 






1. Introduction 1 
Ultraviolet radiation (UVR) is one of the most genotoxic agents that is ubiquitous in 2 
the environment. UVR can affect human skin, causing an inflammatory response of 3 
sunburn (erythema and edema) in the short term (Parrish et al., 1982) and photoaging, 4 
such as wrinkling and pigmentation, in the long term (Rittié and Fisher, 2002; Rabe et al., 5 
2006). In the worst case scenario, UVR exposure can result in carcinogenesis (Brash, 6 
1997). The genotoxicity of UVR originates from its capacity to produce DNA damage, 7 
which can induce mutations in the skin genome, leading to inactivation of genes necessary 8 
for skin homeostasis and activation of genes associated with oncogenic transformation 9 
(Brash, 1997; Ikehata and Ono, 2011). DNA damage can also cause apoptosis in skin 10 
tissue, leading to inflammation (Ziegler et al., 1994). UVR produces DNA damage via 11 
two distinct mechanisms. The first mechanism is direct photoreaction of UVR photons 12 
with DNA pyrimidine bases, leading to formation of dipyrimidine base adducts such as 13 
cyclobutane pyrimidine dimers (CPDs). The second mechanism is an indirect process that 14 
is mediated by production of reactive oxygen species (ROS), such as singlet oxygen (1O2), 15 
via the photosensitization of small organic molecules such as riboflavin and porphyrin 16 
(Cadet et al., 2000, 2012, 2015). ROS can induce oxidative DNA damage, such as the 17 
formation of 8-hydroxyguanine (8OH-G) (Grollman and Moriya, 1993; Cadet et al., 2000, 18 
2015). These two types of UVR-induced DNA damage induce different types of 19 
mutation: CPD and other photolesions specifically induce C to T base substitutions at 20 
dipyrimidine sites whereas ROS-induced 8OH-G induces G to T mutations most 21 
frequently (Ikehata and Ono, 2011). Biological systems, including mammalian skin, 22 
respond to these UVR insults with protective mechanisms, such as DNA repair and 23 
damage avoidance (Marteijn et al., 2014; Friedberg et al., 2002; Livneh et al., 2016).  24 
 
 4 
However, the mechanisms associated with the tolerance of UVR-mediated ROS 1 
hazards remain controversial and have yet to be elucidated (Cadet et al., 2009; Rizzo et 2 
al., 2011; Sage et al., 2012; Premi and Brash, 2016; Ikehata, 2018). One of most likely 3 
candidate mechanisms is the KEAP1 (Kelch-like ECH-associated protein 1)-NRF2 (NF-4 
E2-related factor 2) system, which controls a battery of cytoprotective genes that encode 5 
enzymes that protect cells and tissues from oxidative and electrophilic stress of both 6 
exogenous and endogenous origins (Itoh et al., 1997; Suzuki et al., 2013; Hayes and 7 
Dinkova-Kostova, 2014; Yamamoto et al., 2018). In this review, we survey the literature 8 
regarding the contributions of the KEAP1-NRF2 system to the defense against UVR 9 
toxicity and discuss the roles of this system in the protection of mammalian skin from the 10 
harmful effects of UVR, such as photoaging and carcinogenesis. 11 
2. Protection of the skin from UVR by the KEAP1-NRF2 system 12 
To the best of our knowledge, the first study of the contribution of the KEAP1-NRF2 13 
system to skin protection against UVR genotoxicity was conducted by Talalay’s group 14 
using a UVR-induced skin carcinogenesis model in hairless mice (Dinkova-Kostova et 15 
al., 2006). The study demonstrated that topical and repetitive application of sulforaphane 16 
after repetitive UVR exposure activates the NRF2-controlled antioxidant response in 17 
mouse skin and suppresses the development of skin cancer, reducing tumor incidence and 18 
multiplicity as well as the total tumor volume per mouse. They also found that 19 
postirradiation dietary application of broccoli sprout extracts, which contain 20 
glucoraphanin, a precursor of sulforaphane, delays tumor development in UVR-exposed 21 
mice (Dinkova-Kostova et al., 2010). They further showed that activation of NRF2-22 
dependent cytoprotection by sulforaphane treatment prior to UVR exposure mitigates the 23 
 
 5 
inflammatory responses to UVR, such as edema and erythema, in both mouse and human 1 
skin (Talalay et al., 2007). Thus, both pre- and post-irradiation activation of NRF2 protect 2 
the skin from UVR toxicity. 3 
These observations were partially confirmed in a study with Nrf2-knockout (Nrf2-ko) 4 
mice by Otsuka and colleagues (Kawachi et al., 2008), who reported that Nrf2-ko mice 5 
exhibit greater sensitivity to erythema and dermal edema induced by acute exposure to 6 
UVB than wild-type mice. Inflammatory cell infiltration, appearance of sunburn cells 7 
(apoptotic keratinocytes) and 8OH-G formation were also enhanced in the exposed skin 8 
of Nrf2-ko mice compared with wild-type mice. However, in contrast to the study by 9 
Talalay’s group, little difference was observed in the induction of skin cancer after 10 
chronic exposure to UVB between Nrf2-ko and wild-type mice, although such chronic 11 
exposure accelerated skin photoaging in Nrf2-ko mice, inducing coarse wrinkle formation, 12 
loss of flexibility, epidermal thickening and subepidermal deposition of extracellular 13 
matrix (Hirota et al., 2011). 14 
Subsequently, Dinkova-Kostova and colleagues confirmed the observation in the latter 15 
report, showing that no difference exists in UVR-induced skin carcinogenicity between 16 
Nrf2-ko and wild-type mice (Knatko et al., 2015). However, in the same study, they found 17 
that genetic activation of NRF2, which was induced by Keap1 deficiency, protects mice 18 
from skin carcinogenesis induced by chronic UVR exposure. Furthermore, continuous 19 
pharmacological NRF2 activation with the potent NRF2 activator TBE-31 before and 20 
during chronic UVR treatment was found to suppress the development of skin cancers as 21 
measured by tumor multiplicity and volume per mouse,. In contrast to the study by 22 
Otsuka’s group, Knatko et al. (2015) showed that genetic inactivation of NRF2 did not 23 
 
 6 
enhance the acute skin response to UVR, such as erythema, while the response was 1 
suppressed significantly by genetic NRF2 activation (Table 1). 2 
The discrepancies between these findings may be attributable to the use of different 3 
UVR sources because the severity and quality of the effects of UVR depend on the 4 
wavelength (Ikehata et al., 2013). UVR is subdivided by wavelength into UVC (< 280 5 
nm), UVB (280–320 nm) and UVA (320–400 nm), and the UVR toxicity is usually higher 6 
at shorter wavelengths although the UVC components are largely blocked by the 7 
epidermal cornified layer. The emission spectrum of the UVB lamps used by Otsuka’s 8 
group was shifted to a shorter wavelength range than that of the UVR source used by 9 
Dinkova-Kostova’s group, so the results in the former study should reflect the effects of 10 
shorter wavelengths, which are the more erythematic and inflammatory components of 11 
UVR. 12 
Importantly, taken together, the results of both studies demonstrate that NRF2 plays a 13 
protective role against chronic UVR exposure. Otsuka’s group showed that NRF2 is 14 
necessary for protection of the skin from photoaging, while Talalay and colleagues 15 
showed that continuous NRF2 activation suppresses or delays the development of skin 16 
cancer. Because UVB does not efficiently activate NRF2 in the skin or skin cells (Hirota 17 
et al., 2005; Durchdewald et al., 2007), it may not be surprising that no difference in skin 18 
carcinogenesis was observed between Nrf2-ko and wild-type mice after chronic UVB or 19 
solar-simulated UVR exposure. These studies indicate that, in the presence of chronic 20 
UVR exposure, continuous activation of NRF2 in normal skin is necessary to prevent or 21 
delay skin tumor growth whereas basal NRF2 activity is sufficient to suppress skin 22 
photoaging (Table 1). 23 
3. Effects of genetic NRF2 activation on the skin 24 
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While the activation of NRF2 provides protection against UVR genotoxicity in skin 1 
tissues, continuous NRF2 activation may not always be beneficial for skin health. Werner 2 
and colleagues constructed an N-terminal-whole-Neh2-domain-deleted Nrf2 cDNA, 3 
which produces a constitutively active NRF2 (caNRF2) protein because of the lack of the 4 
ability to interact with KEAP1. They generated a series of transgenic mouse lines 5 
expressing the caNrf2 gene with a floxed stop cassette in the epidermis. 6 
The first caNrf2 transgenic mouse line harbored the transgene under the control of the 7 
b-actin promoter and a Cre transgene that is specifically expressed in the epidermis. The 8 
transgenic mice exhibited significant reduction of apoptosis in the epidermis after UVB 9 
exposure compared to the nontransgenic control mice (Schäfer et al., 2010). With this and 10 
related transgenic mouse lines, they identified a descending gradient of NRF2 activation 11 
levels from suprabasal to basal cell layers in the epidermis. This result is consistent with 12 
the observation that suprabasal cells are more resistant to UVR-induced apoptosis than 13 
basal cells (Schäfer et al., 2010). Thus, the activation of NRF2 seems favorable for 14 
protection of the skin from UVR. Importantly, this line of transgenic mice exhibits mild 15 
hyperkeratosis in the skin. 16 
Werner and colleagues constructed another transgenic mouse line overexpressing the 17 
caNrf2 gene under the control of a CMV enhancer/β-actin promoter specifically in the 18 
epidermis (Schäfer et al., 2012). Mice expressing caNRF2 from this transgene exhibited 19 
reduced body size and hair malformation and loss. These mice exhibited prominent 20 
anomalies in their epidermal structure, for example, epidermal thickening, hyperkeratosis, 21 
corneocyte fragility and impaired desquamation, showing a lamellar ichthyosis-like 22 
phenotype at the early ages of 1-3 months. The mice were also defective in epidermal 23 
barrier function, resulting in skin dryness and an inflammatory response, with increased 24 
 
 8 
infiltration of T cells, mast cells and neutrophils into the dermis. In addition, they 1 
exhibited abnormalities of hair follicles and sebaceous glands (Schäfer et al., 2014) (Fig. 2 
1). 3 
Notably, the caNRF2-overexpressing mice exhibited thickening and hyperkeratosis not 4 
only in the interfollicular epidermis but also in hair follicles, developing dilatation of the 5 
infundibula, which may have been responsible for the hair malformation and loss. Hair 6 
follicle dilatation was accompanied by enlarged sebaceous glands, which further 7 
developed seborrhea and cysts upon aging, exhibiting phenotypes reminiscent of 8 
chloracne/metabolizing acquired dioxin-induced skin hamartomas (MADISH). Werner’s 9 
group noted that NRF2-dependent, prolonged upregulation of three epidermis-specific 10 
genes, namely Sprr2d (small proline-rich protein 2d), Slpi (secretory leukocyte peptidase 11 
inhibitor) and Epgn (epigen), causes these abnormal skin phenotypes in transgenic 12 
caNRF2-overexpressing mice. However, the adverse effects on the skin observed in the 13 
caNRF2 mice, especially the overexpression mice, should be noted with caution because 14 
such extreme conditions of NRF2 activation would hardly be achievable in normal mice 15 
even after treatments with strong NRF2 inducers. 16 
4. Responses of the NRF2 system to UVR in skin cells and tissues 17 
The level of basal expression of the Nrf2 gene is relatively high in human skin 18 
(Fagerberg et al., 2014) but differs among the primary human skin cells of keratinocytes, 19 
fibroblasts and melanocytes. Basal Nrf2 gene expression is approximately twofold higher 20 
in keratinocytes than in fibroblasts and melanocytes (Reemann et al., 2014). Although 21 
NRF2 is activated post-translationally through KEAP1 inactivation by various 22 
environmental stressors (Suzuki et al., 2013; Hayes and Dinkova-Kostova, 2014), UVR 23 
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appears to be a poor activator of NRF2 (Hirota et al., 2005; Durchdewald et al., 2007; 1 
Marrot et al., 2008; Kokot et al., 2009). The available lines of evidence indicate that UVR, 2 
especially UVB, downregulates the activity of NRF2 and expression of the corresponding 3 
target genes in skin fibroblasts and keratinocytes in vitro and in skin tissues in vivo (Table 4 
2). Because UVR produces DNA base damage such as CPDs that strongly inhibit 5 
transcription (Kwei, et al., 2004; Scicchitano et al., 2004; Tornaletti, 2005), UVR would 6 
consequently retard the activation of NRF2-mediated transcription. Whereas UVR can 7 
also produce ROS, such DNA damage occurs instantly upon irradiation via direct 8 
photochemical mechanisms prior to ROS generation and acts to prevent the prompt and 9 
efficient upregulation of NRF2-target genes (Fig. 2). Although the possibility of NRF2-10 
specific transcriptional regulation against UVR cannot be excluded, the remarkable 11 
reduction of nuclear NRF2 levels after UVB exposure (Hirota et al., 2005) suggests that 12 
the KEAP1-dependent degradation depletes NRF2 because of the cessation of NRF2 13 
synthesis by the UVR-mediated general transcriptional block. In fact, downregulation of 14 
Nrf2 gene expression by UVB was observed in primary human keratinocytes by RNA-15 
seq analysis (Shen et al., 2017). Interestingly, Williamson et al. (2017) proposed a short 16 
transcript-dependent mechanism of recovery from the general transcriptional block by 17 
UVR, which would aid the reactivation of the NRF2 pathway. 18 
Notably, however, there are a few reports indicating that UVA induces NRF2-19 
dependent cytoprotection because UVA produces transcription-blocking DNA damage 20 
much less efficiently than UVB (Setlow, 1974; Matsunaga et al., 1991) (Fig. 2). In this 21 
regard, Tyrrell and colleagues reported that a 32-kDa protein, which has now been 22 
identified as heme oxygenase 1 (HO-1), is induced in human skin fibroblasts after 23 
exposure to UVA (Keyse and Tyrrell, 1987, 1989). HO-1 is a stress-inducible 24 
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antioxidative enzyme that is transcriptionally regulated under the control of NRF2 (Ishii 1 
et al., 2000; Alam et al., 1999), whereas hypoxia or ROS-mediated, NF-kB or HIF-1-2 
dependent pathways are also known to upregulate HO-1 (Wu et al., 2004; Ryter and Choi, 3 
2005; Lien et al., 2014). Tyrrell’s group confirmed that UVA-mediated HO-1 induction 4 
is NRF2 dependent and protects cells from membrane damage caused by UVA (Zhong et 5 
al., 2010). HO-1 induction by UVA is not confined to fibroblasts, as this phenomenon 6 
has also been detected in human keratinocytes by another group (Marrot et al., 2008). In 7 
addition, Tyrrell’s group also demonstrated that glutathione (GSH) depletion sensitizes 8 
cultured human keratinocytes and fibroblasts to UVR, especially to longer wavelengths 9 
in the UVA range, and that this sensitization is more prominent for fibroblasts than for 10 
keratinocytes (Tyrrell and Pidoux, 1988). This study could be another example of the 11 
contribution of the KEAP1-NRF2 system to the protection against UVR toxicity because 12 
the cellular GSH level is known to be controlled by GSH-metabolizing enzymes, such as 13 
glutamate-cysteine ligase (GCL), cystine/glutamate transporter xCT and GSH S-14 
transferases, many of which are regulated by NRF2 (Suzuki et al., 2013; Hayes and 15 
Dinkova-Kostova, 2014). The relatively poor sensitization of keratinocytes to UVR by 16 
the less efficient GSH depletion has been reproduced in mice lacking the modifier subunit 17 
of GCL, in which the GSH level is reduced by 70% in the skin, as shown by the 18 
frequencies of UVR-induced sunburn cells (Telorack et al., 2016a). 19 
Direct evidence for the UVA-mediated activation of NRF2 was first reported by 20 
Otsuka and colleagues (Hirota et al., 2005). They detected significant NRF2 21 
accumulation in the nuclei of mouse dermal fibroblasts in vitro after exposure to UVA 22 
but not UVB (Table 2). NRF2 upregulation suppresses UVA-induced apoptosis of dermal 23 
fibroblasts, which they demonstrated by using Nrf2-ko and Keap1-ko mutant cells (Table 24 
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1). Gruber et al. (2010) also demonstrated NRF2 upregulation by UVA in human dermal 1 
fibroblasts, which is mediated by UVA-oxidized phospholipids. In addition, NRF2 2 
accumulation was observed in melanocytes and melanoma cells after UVA exposure, and 3 
the accumulated NRF2 further upregulated the autophagy receptor adaptor p62 in an 4 
ROS-production-dependent manner (Sample et al., 2018). On the other hand, Werner’s 5 
group reported that UVA, as well as UVB, does not activate the KEAP1-NRF2 system in 6 
mouse keratinocytes in vitro and in vivo (Durchdewald et al., 2007) (Table 2), although 7 
this observation does not necessarily exclude a protective ability of NRF2 against UVR. 8 
In fact, NRF2 activation prior to irradiation with electrophilic chemicals protects 9 
keratinocytes from UVA-induced apoptosis (Kimura et al., 2009) (Table 1). The 10 
differences in the NRF2 responses to UVA between Werner’s study and the others might 11 
be due to differences in the cell types used or due to the use or lack thereof of filters that 12 
cut off the shorter wavelengths in the UVB range emitted from UVA sources. Because 13 
the photochemical and photobiological effectiveness of UVB is much more powerful than 14 
that of UVA, UVB contamination, which would be expected in the study by Werner’s 15 
group, could mask the effects of UVA (Ikehata et al., 2013) (Fig. 2). 16 
Thus, UVA seems to be able to activate the KEAP1-NRF2 system, at least in skin 17 
fibroblasts in vitro (Hirota et al., 2005; Zhong et al., 2010; Gruber et al., 2010) and in 18 
melanocytes (Marrot et al., 2008; Sample et al., 2018). However, the NRF2 upregulation 19 
observed in these studies was often dependent on the presence of heme; the repletion and 20 
depletion of heme in cells strongly stimulates and suppresses the upregulation, 21 
respectively (Hirota et al., 2005; Zhong et al., 2010). Porphyrin is known to be a potent 22 
photosensitizer that is activatable by visible light and UVA and can produce 1O2 (Cadet 23 
et al., 2000). It has also been reported that hydrogen peroxide (H2O2) and oxidized 24 
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phospholipids can activate HO-1 and the KEAP1-NRF2 system in fibroblasts (Keyse and 1 
Tyrrell, 1989; Gruber et al., 2010; Saito et al., 2016). Hence, NRF2 activation by UVA 2 
most likely occurs due to ROS production via UVA-activatable photosensitizing 3 
molecules such as porphyrin and riboflavin (Fig. 2). Because the levels of 4 
photosensitizable ingredients in cultured media influence the cellular levels of ROS after 5 
UVA exposure (Besaratinia et al., 2007), cell culture conditions could artificially affect 6 
the extent of NRF2 activation by UVA. 7 
In contrast to the results observed with fibroblasts, NRF2 activation is not always 8 
observed in keratinocytes after UVA exposure or even after H2O2 treatment, although 9 
these treatments strongly increase the intracellular ROS level (Durchdewald et al., 2007) 10 
(Table 2). The reason why keratinocytes and fibroblasts respond differentially to UVA is 11 
currently unknown. One possibility is that keratinocytes possess a more secure 12 
antioxidant ability than fibroblasts. In fact, the level of GSH and the resistance to the GSH 13 
synthesis inhibitor buthionine-S,R-sulfoximine (BSO) were reported to be higher for 14 
human keratinocytes than for dermal fibroblasts (Tyrrell and Pidoux, 1988). It was also 15 
reported that UVA reduces cellular GSH levels more drastically in human fibroblasts than 16 
in keratinocytes (Niggli and Applegate, 1997). Interestingly, conditional Gclc-ko mice 17 
that lack the catalytic subunit of GCL and are completely deficient in GSH synthesis in 18 
the epidermis exhibit an increased level of keratinocyte apoptosis even in the absence of 19 
UVR exposure (Telorack et al., 2016b), indicating an essential role of GSH in the 20 
maintenance of healthy skin. 21 
Regarding the observations that UVB does not activate, or often downregulates, the 22 
KEAP1-NRF2 system in keratinocytes in vitro and in vivo (Durchdewald et al., 2007; 23 
Kokot et al., 2009) and even in fibroblasts in vitro (Hirota et al., 2005) (Table 2), Kokot 24 
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et al. (2009) made the intriguing finding that α-melanocyte-stimulating hormone (α-1 
MSH), which is induced by UVR in a p53-dependent manner (Cui et al., 2007), can 2 
activate the KEAP1-NRF2 system by itself to counteract NRF2 downregulation by UVB 3 
in keratinocytes in vitro and in skin ex vivo organ culture. α-MSH was also found to 4 
protect skin cells from UVR-induced apoptosis by upregulating DNA repair for CPD  5 
removal (Böhm et al., 2005; Kadekaro et al., 2005; Dong et al., 2010). Because 6 
keratinocytes can secrete α-MSH and can impact their own behavior via autocrine and 7 
paracrine mechanisms, it is conceivable that UVR-induced α-MSH can protect cell 8 
populations such as the skin epidermis in which cells adhere closely to each other, by 9 
infiltrating the whole tissue and activating DNA repair and the KEAP1-NRF2 system. 10 
The a-MSH-mediated protection would be much more efficient for such a closely 11 
congregated cell population than for a scattered or less closely distributed population, 12 
such as cultured cells or the fibroblasts in the dermis. Further studies are expected to 13 
clarify these points. 14 
5. The role of NRF2 in the protection of skin against photoaging 15 
NRF2 can prevent skin photoaging, which is a harmful effect of UVR that affects the 16 
appearance of individuals as well as their skin health (Hirota et al., 2011). UVR is known 17 
to promote skin photoaging via upregulation of matrix metalloproteinases (MMPs) that 18 
degrade the extracellular matrix in the skin dermis by cleaving collagen and elastin, 19 
resulting in destruction of the dermal matrix that can cause deep wrinkles in the affected 20 
skin (Herrmann et al., 1993; Fisher et al., 1996; Brenneisen et al., 1996). In addition, it 21 
has been demonstrated that MMPs are also induced by 1O2 (Wlaschek et al., 1995), which 22 
can be produced in cells and tissues after UVA exposure (Cadet et al., 2000). 23 
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As shown in Fig. 3, MMP upregulation is mediated by the activation of growth-factor 1 
and cytokine receptors that possess intracellular tyrosine kinase domains, which are 2 
negatively regulated by protein tyrosine phosphatases (PTPs). The activated tyrosine 3 
kinases of the receptors upregulate downstream signaling cascades such as the MAP 4 
kinase cascade, which then mediates the induction of MMP gene expression by activating 5 
the transcription factor AP-1 (Fisher et al., 1996). UVR induces MMP activity in the 6 
dermis by inactivating the PTPs via the oxidation of a critical active-site cysteine residue 7 
(Denu and Tanner, 1998; Rittié and Fisher, 2002). PTP inactivation by ROS is suppressed 8 
by peroxiredoxin (PRX) (Choi et al., 2005), which is recycled in the redox state by 9 
thioredoxin (TRX), TRX reductase 1, and sulfiredoxin (SRX) (Neumann et al., 2009) 10 
(Fig. 3, right). Recently, it was also reported that TRX reductase 1 itself can directly 11 
protect PTPs (Dagnell et al., 2017). Because some of the genes encoding PRX (PRDX1 12 
and PRDX6), TRX, TRX reductase and SRX have been shown to be targets of NRF2 13 
(MacLeod et al., 2009; Malhotra et al., 2010; Agyeman et al., 2012; Chorley et al., 2012; 14 
Hirotsu et al., 2012; Jung et al., 2013; Hawkes et al., 2014), the KEAP1-NRF2 system is 15 
expected to prevent skin photoaging by suppressing MMP induction via the protection of 16 
PTPs from the oxidative inactivation mediated by UVR.  17 
Interestingly, Scharffetter-Kochanek’s group has shown that the UVR-induced 18 
activation of MMPs in human dermal fibroblasts is mediated through autocrine action by 19 
interleukin-6 (IL-6), whose production is upregulated by NF-kB signaling. They 20 
observed that NF-kB/IL-6 signaling is activated through UVR-mediated intracellular or 21 
extracellular ROS production (Wlaschek et al., 1993, 1997; Brenneisen et al., 1999; Wenk 22 
et al., 2004). In these studies, they indicated that UVA-generated extracellular 1O2 induces 23 
lipid peroxidation in the cell membrane and that lipid peroxidation produces 24 
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phosphatidylcholine hydroperoxide, which upregulates the NF-kB/IL-6 signaling 1 
pathway in human dermal fibroblasts and eventually leads to MMP induction. 2 
Importantly, UVA-mediated MMP induction is abrogated by the overexpression of 3 
phospholipid-hydroperoxide glutathione peroxidase or glutathione peroxidase 4 (GPX4) 4 
(Wenk et al., 2004). GPX4 might be activatable by the KEAP1-NRF2 system because a 5 
NRF2-MAFG binding site has been detected in the vicinity of the mouse Gpx4 gene 6 
(Hirotsu et al., 2012). Thus, NRF2 might be able to suppress skin photoaging via another 7 
NRF2-dependent antioxidative pathway involving GPX4 (shown to the left in Fig. 3) in 8 
addition to the pathway involving TRX and PRX (shown to the right in Fig. 3).  9 
6. Involvement of NRF2 in the prevention and promotion of skin carcinogenesis 10 
The mutagenicity and apoptosis inducibility of UVR are both thought to contribute to 11 
its carcinogenicity: the former produces oncogenic mutations necessary for tumorigenic 12 
initiation, whereas the latter causes tumor-promoting inflammation (Ziegler et al., 1994). 13 
As mentioned above, UVR induces these mutations in two different ways, namely, via 14 
ROS-dependent and independent pathways, and the former would be prevented by NRF2 15 
activation (Fig. 2). Similarly, UVR causes apoptosis via two different mechanisms, i.e., 16 
ROS-dependent and ROS-independent mechanisms. The start-up kinetics of these 17 
mechanisms differ, with the former occurring much earlier than the latter (<0.5 h vs. >4 18 
h) (Godar, 1999). The latter apoptotic process (delayed apoptosis) is induced by the 19 
formation of DNA damage such as CPD, whereas the former (immediate apoptosis) is 20 
triggered by ROS such as 1O2, which are produced by UVR-mediated photosensitization 21 
and can damage the mitochondrial membrane (Godar, 2000; Simon et al., 2000). These 22 
processes also show a wavelength dependence; delayed apoptosis is caused mainly by 23 
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short wavelengths, such as UVC and UVB, whereas immediate apoptosis is induced by 1 
UVA, especially the longer range UVA1 (340–400 nm) (Godar and Lucas, 1995). The 2 
antioxidative activities induced by NRF2 would be expected to suppress the ROS-3 
mediated immediate apoptosis triggered by UVA exposure. Thus, NRF2 activation can 4 
suppress the development of UVR-induced skin cancers by preventing ROS-mediated 5 
oncogenic mutations and apoptosis in the skin (Fig. 2). Although apoptosis can eliminate 6 
damaged cells that could transform into precancerous cells if they survived, apoptosis 7 
also produces empty spaces in affected tissues, which would allow the surrounding, less 8 
damaged cells to proliferate to fill the spaces. Such proliferation of lightly damaged cells 9 
could induce mutations including oncogenic ones. Mutation induction by hyperplasia in 10 
mouse skin epidermis after UVR-induced apoptosis has been reported (Ikehata et al., 11 
2010). 12 
In fact, sustained NRF2 activation protects the skin from UVR-induced carcinogenesis, 13 
as mentioned above (Dinkova-Kostova et al., 2006, 2010; Knatko et al., 2015). However, 14 
the underlying mechanism remains under investigation. The roles of the KEAP1-NRF2 15 
system in skin carcinogenesis were explored by Schäfer and colleagues using chemical 16 
and genetic models of skin carcinogenesis (Rolfs et al., 2015), in which the low epidermal 17 
expression caNrf2-transgenic mice mentioned above were utilized (Schäfer et al., 2010). 18 
They found that NRF2 contributes to skin cancer development differently in these 19 
different models. In the chemical model of carcinogenesis, in which mice were treated 20 
once with the mutagen DMBA (7,12-dimethylbenz[a]anthracene) and repeatedly 21 
thereafter with the tumor promoter TPA (12-O-tetradecanoylphorbol 13-acetate), NRF2 22 
activation suppressed tumorigenesis, although the extent of suppression was low. By 23 
contrast, NRF2 activation remarkably promoted tumorigenesis in the genetic model, in 24 
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which mice harbored transgenic HPV8 (human papilloma virus 8) oncogenes expressed 1 
specifically in the epidermis. The difference between the chemical and genetic models 2 
was the frequency of precancerous cells in the epidermis at the beginning of the 3 
experiment; the frequency was low or nearly zero in the former but 100% in the latter, 4 
with active oncogenes present in all cells. Because they also demonstrated that NRF2 5 
activation does not promote cell proliferation but does promote cell survival by 6 
suppressing ROS-induced apoptosis, they argued that NRF2 activation should favor the 7 
development of skin cancer by protecting precancerous keratinocytes from ROS-induced 8 
apoptosis. The protective capacity of NRF2 activation toward cancer cells has also been 9 
reported in previous studies (Wang et al., 2008; Jaramillo and Zhang, 2013). 10 
However, the contribution of noncancerous, normal populations of keratinocytes 11 
should not be ignored in the chemical model of carcinogenesis because the KEAP1-NRF2 12 
system is also upregulated as highly in the normal population as in the small number of 13 
initiated precancerous keratinocytes. The lower efficiency of tumorigenesis in the NRF2-14 
activated mice than in the control mice in the chemical model of carcinogenesis could be 15 
the result of a competition between normal and precancerous keratinocytes in the 16 
epidermis, which suggests that NRF2 activation can confer an advantage to normal cells 17 
to counteract precancerous cells (Fig. 4, left). The study by Knatko et al. (2015) supports 18 
this idea because mice with genetic activation of NRF2 exhibited greater resistance to 19 
UVR-induced skin carcinogenesis than wild-type mice, which indicates that NRF2-20 
activated normal keratinocytes can also compete with UVR-initiated precancerous cells 21 
more effectively than nonactivated keratinocytes. The advantage of sustained NRF2 22 
activation for the prevention of carcinogenic initiation has also been demonstrated in a 23 
mouse model of urethane-induced lung cancer using Keap1-knockdown (kd) mice, which 24 
 
 18 
express a high level of NRF2 (Satoh et al., 2016). Thus, continuous NRF2 activation 1 
during carcinogenic treatments in normal cells, whether it is achieved genetically (e.g., 2 
caNrf2 or Keap1-kd) or pharmacologically (e.g., sulforaphane or TBE-31), is expected to 3 
suppress the expansion of precancerous cells in the tissue. 4 
Importantly, the lung cancer study by Satoh et al. further provided evidence that NRF2 5 
activation accelerates tumor development to the contrary once the cells have transformed 6 
into a tumorigenic state, by testing in nude mice the tumorigenicity of the urethane-7 
induced lung tumor cells derived from the Keap1-kd mice (Satoh et al., 2016), a condition 8 
that is similar to the carcinogenically initiated keratinocytes in the genetic model of skin 9 
cancer mentioned above (Rolf et al., 2015). UVR causes not only mutations, some of 10 
which could be oncogenic, but also apoptotic cell death in the affected skin tissue, which 11 
can induce hyperplastic cell proliferation to reconstitute the damaged tissue (Ikehata et 12 
al., 2010). Repetitive UVR exposure, which is required to induce skin cancer, would 13 
cause inflammation, a condition in which simultaneous cell division and death occur 14 
perpetually, through inflammasome activation (Feldmeyer et al., 2007; Nasti and Timares, 15 
2012). In such inflammatory conditions, there is competition among surviving cells, some 16 
of which acquire oncogenic mutations during proliferation, finally leading to the 17 
formation of skin cancer, which is almost an inevitable outcome as long as the 18 
inflammation does not subside (de Gruijl and Forbes, 1995). Prolonged inflammation 19 
favors cancer development because such sustained inflammatory states accumulate 20 
oncogenic mutations, which could synergistically enhance the proliferation and survival 21 
of the affected cells, i.e., initiated cells (Ziegler et al., 1994; Jonason et al., 1996) (Fig. 4, 22 
right). Immediate and efficient damping of inflammation is therefore necessary to 23 
 
 19 
suppress skin cancer development by UVR. NRF2 activation is known to inhibit the 1 
inflammasome and consequently inflammation (Hennig et al., 2018). 2 
As mentioned previously, Schäfer and colleagues proved that the promotion of skin 3 
tumorigenesis by NRF2 activation occurs due to the improvement of the survival of 4 
cancer cells by the suppression of ROS-induced apoptosis, not due to the enhancement of 5 
proliferation (Rolf et al., 2015). They further provided evidence that the improvement of 6 
survival would be brought about by a metabolic adaptation to the 7 
inflammatory/tumorigenic microenvironment that can expose cells to apoptotic stimuli 8 
such as ROS (Rolf et al., 2015). It is known that NRF2 activation causes a metabolic 9 
alteration in affected cells, upregulating the pentose phosphate pathway and GSH 10 
synthesis, which increases the intracellular ATP/GTP, NADPH and GSH levels, thereby 11 
enhancing cell proliferation and survival by providing energy sources and antioxidative 12 
conditions (Mitsuishi et al., 2012). 13 
This metabolic reprogramming can also be beneficial for uninitiated, normal cells, at 14 
least at the early stages of carcinogenesis, because these cells overwhelmingly outnumber 15 
the initiated precancerous cells, so that they can rapidly occupy empty spaces in the tissue 16 
resulting from apoptosis and prevent the expansion and further mutagenic transformation 17 
of precancerous cells, as evidenced by the observations for NRF2-activated mice in the 18 
models of urethane-induced lung tumorigenesis (Satoh et al., 2016) and UVR-induced 19 
skin carcinogenesis (Knatko et al., 2015). In contrast, at the later stages, NRF2 activation 20 
would be rather beneficial for precancerous/cancerous cells because oncogenic mutations 21 
provide these cells with increased proliferation and survival abilities that can be enhanced 22 
by NRF2 upregulation (Fig. 4). Nrf2-activating mutations themselves have been detected 23 
 
 20 
as candidate oncogenic mutations in various human cancers (Yamamoto et al., 2018; De 1 
la Vega et al., 2018). 2 
Although it has also been reported that functional NRF2 is necessary to support the 3 
stable growth of lung tumors without regression (Satoh et al., 2013), this requirement for 4 
NRF2 function was not observed for UVR-induced skin cancers (Kawachi et al., 2008; 5 
Knatko et al., 2015). This discrepancy might originate from the different modes of 6 
carcinogen treatment: urethane was administered by a single dose only at the beginning 7 
of the experiment, whereas UVR was provided repetitively for a fairly long period in the 8 
earlier steps of the experiment, which suggests some activity of UVR for tumor promotion 9 
that is equivalent to the function of NRF2 necessary for the maintenance of lung 10 
tumorigenesis. In fact, it was reported that UVR-induced precancerous keratinocyte 11 
patches in the epidermis that harbored presumed p53 mutations regressed remarkably 12 
after discontinuation of the repetitive exposure (Berg et al., 1996). 13 
7. Conclusion 14 
UVR affects the genome and tissue of the skin due to its DNA-damaging and ROS-15 
producing abilities, which cause mutations and apoptosis in the skin, leading to 16 
photoaging and carcinogenesis after repetitive exposure. This toxicity of UVR toward the 17 
skin is mediated by two pathways, i.e., ROS-dependent and ROS-independent pathways. 18 
The latter is triggered by DNA damage formed by direct photoreaction with DNA. The 19 
effects of the latter pathway are induced mainly by the short wavelengths of UVR, namely, 20 
UVC and UVB, whereas those of the former pathway are brought about not only by 21 
UVC/UVB but also by the long-wavelength component UVA, which all produce ROS 22 
via photochemical activation of photosensitizable biomolecules such as porphyrins. The 23 
 
 21 
KEAP1-NRF2 system can prevent or mitigate the harmful effects of UVR caused by the 1 
ROS-dependent pathway by activating a battery of antioxidative activities, although this 2 
system seems unable to prevent the ROS-independent toxicity of UVR. The ROS-3 
dependent UVR toxicity toward the skin is involved in photoaging and cancer formation, 4 
both of which can be suppressed by the activation of NRF2. NRF2 activation could 5 
suppress the initiation step of carcinogenesis by preventing ROS-induced mutations and 6 
apoptosis and enhancing the survival of noncancerous normal cells, although prolonged 7 
activation would be rather detrimental to skin cancer prevention because it preferentially 8 
promotes the survival of precancerous cells that have acquired oncogenic mutations 9 
advantageous for proliferation in the affected skin. Precise evaluation of the role of 10 
KEAP1-NRF2 system in the control of ROS-dependent UVR toxicity for the skin still 11 
requires detailed studies on the downstream pathways of the system that function in the 12 
skin to prevent UVR-induced mutation, apoptosis, inflammation and photoaging, 13 
whereas consideration for the ROS-independent pathway is also necessary to estimate the 14 
exact contribution of NRF2 to skin protection against the overall harmfulness of UVR.  15 
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Figure captions 1 
 2 
Fig. 1. Effects of genetic NRF2 activation on the skin. According to studies by Werner 3 
and colleagues, genetically activated NRF2 can protect skin against environmental toxic 4 
agents at low expression levels, whereas extremely high expression of this gene has 5 
various adverse effects on the skin, such as anomalies in the structure of the epidermis, 6 
hair follicles and sebaceous glands that can develop into seborrhea and cysts upon aging. 7 
 8 
Fig. 2. Involvement of NRF2 in the ROS-dependent and ROS-independent pathways that 9 
mediate the toxicity of UVR toward the skin. The toxic effects of UVR are wavelength 10 
dependent. Short wavelengths in the UVC/UVB range produce DNA base damage via 11 
direct photoreaction with DNA (ROS-independent pathway), whereas this effect 12 
decreases substantially at wavelengths in the UVA range, which exert toxicity mainly via 13 
ROS production by photosensitizing biomolecules in cells and tissues (ROS-dependent 14 
pathway). This UVR-produced DNA damage and ROS induce mutations and apoptosis 15 
in affected tissues irrespective of the pathway and can cause inflammation, photoaging 16 
and cancers in the skin. The activation of NRF2 can protect against UVR toxicity by 17 
upregulating a battery of antioxidative activities to counteract the ROS-dependent 18 
pathway; however, NRF2 activation has little suppressive effect on the UVR toxicity due 19 
to the ROS-independent pathway because the potent ability of UVC/UVB to produce 20 
DNA base damage leads to downregulation of NRF2 via transcriptional inhibition. 21 
 22 
Fig. 3. Schematic diagram of a hypothetical cellular mechanism for the control of skin 23 
photoaging. Repetitive UVR exposure causes skin photoaging by upregulating matrix 24 
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metalloproteinases in dermal fibroblasts. ROS-mediated intra/intercellular signaling 1 
pathways are thought to be involved in the upregulatory mechanism. A group of 2 
antioxidative enzymes, many of which are under the control of NRF2, can suppress 3 
photoaging by reducing the levels of UVR-induced ROS and lipid peroxidation products. 4 
aPTP, active protein tyrosine phosphatase; GPX, glutathione peroxidase; iPTP, inactive 5 
PTP; LPO, lipid peroxidation; MMPs, matrix metalloproteinases; PCOOH, 6 
phosphatidylcholine hydroperoxide; PRX, peroxiredoxin; PTK, protein tyrosine kinase; 7 
SRX, sulfiredoxin; TRX, thioredoxin. 8 
 9 
Fig. 4. Hypothetical model of NRF2 involvement in UVR-induced skin cancer 10 
development. UVR induces skin cancers via ROS-dependent (black dashed arrows) and 11 
ROS-independent (gray dashed arrows) pathways, both causing mutations and apoptosis. 12 
Although apoptosis can eliminate damaged cells that could otherwise transform into 13 
precancerous cells, apoptotic tissue destruction also induces cell proliferation, which 14 
usually restores the skin tissue to its normal state while simultaneously being able to 15 
induce mutations. The mutations induced directly by UVR and indirectly during such 16 
proliferation are likely to include oncogenic mutations, which often promote the 17 
proliferative ability of affected cells (the initiation step of tumorigenesis). Once such 18 
oncogenic mutations are acquired, cells become precancerous, attaining an increased 19 
ability to proliferate and survive compared to other normal cells in the tissue (red arrow). 20 
Such precancerous cells acquire additional oncogenic mutations directly or by repeated 21 
proliferation in response to apoptosis during repetitive UVR exposure, gradually 22 
acquiring increasing proliferative abilities that are sufficient to outcompete the 23 
surrounding normal or low-potency precancerous cells (the promotion step). The KEAP1-24 
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NRF2 system can prevent the initiation step by suppressing ROS-induced mutations and 1 
apoptosis after UVR exposure but can also enhance cancer development at the promotion 2 





Table 1 1 
Summary of studies on the protection of the skin against the toxic effects of UVR by 2 
NRF2. 3 
UVR toxicity Basal NRF2 
Activated NRF2 
Chemical Genetic 
Acute    
Apoptosis + (fibroblast)1 + (keratinocyte)2 + (fibroblast)1 
Inflammation (erythema/edema) +3 or –4 +5 +4 
Chronic    
Photoaging +6 ND ND 
Carcinogenesis –3,4 +4,7 +4 
+: significant/marked protection; -: no significant/marked protection; ND: not determined. 1 4 
Hirota et al., 2005; 2 Kimura et al., 2009; 3 Kawachi et al., 2008; 4 Knatko et al., 2015; 5 5 
Talalay et al., 2007; 6 Hirota et al., 2011; 7 Dinkova-Kostova et al., 2006, 2010. 6 
 7 
Table 2 8 
NRF2 responses to UVB and UVA in different skin cell types.  9 
 NRF2 activation in 
 Keratinocytes Fibroblasts Melanocytes 
UVB –1,2 –3 –2 
UVA –1 or +4 +3,5,6 +4,7 
+: significant/marked NRF2 activation; -: no significant/marked activation.  10 
1 Durchdewald et al., 2007; 2 Kokot et al., 2009; 3 Hirota et al., 2005; 4 Marrot et al., 11 
2008; 5 Gruber et al., 2010; 6 Zhong et al., 2010; 7 Sample et al., 2018. 12 
Fig. 1. Ikehata and Yamamoto
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